Central Arkansas Veteran's Healthcare System — Little Rock, Arkansas

Central Arkansas Veteran's Healthcare System is a clinical research site located in Little Rock, Arkansas, United States 72143.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Central Arkansas Veteran's Healthcare System has participated in 13 clinical trials with 2 currently active.

Therapeutic areas: Carotid Stenosis, Diabetes Mellitus, Type 2, Peripheral Arterial Disease.

Sponsors: Mayo Clinic, Novo Nordisk A/S, AnGes USA, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Little Rock

Browse all research sites in Arkansas · View every site in Little Rock

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Arkansas Veteran's Healthcare System?

Central Arkansas Veteran's Healthcare System has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Arkansas Veteran's Healthcare System conducted?

Central Arkansas Veteran's Healthcare System has 13 clinical trials on record, with 2 currently active. Their work covers Carotid Stenosis, Diabetes Mellitus, Type 2, Peripheral Arterial Disease.

Is Central Arkansas Veteran's Healthcare System accredited by Crixeo Clinical Trials?

Central Arkansas Veteran's Healthcare System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Arkansas Veteran's Healthcare System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.